Should You Buy FOXO Technologies Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, FOXO Technologies Inc. (FOXO) scores 3.9/10 on our Quality of Company framework, indicating mixed operational fundamentals. At the current price of $0.09, our multi-model valuation analyzes whether the market has already discounted these weaknesses.
The short answer: 0 of 0 CirclFi valuation models project upside for FOXO Technologies Inc. (FOXO) at $0.09 — the models are evenly split, with a Quality Score of 3.9/10 and Value-Trap risk of 53/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for FOXO Technologies Inc. (FOXO) in 2026?
What Is the Bull Case vs the Bear Case for FOXO Technologies Inc. (FOXO)?
| Bull case | Bear case |
|---|---|
| No active model projects meaningful upside for FOXO at $0.09. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. | No active model flags significant downside for FOXO. The Value Trap score of 53/100 still argues for some caution. |
How Does FOXO Compare to Its Medical Care Facilities Peers?
Valuation data pages: HLYK · PARK · CMPS · GMRS · PIII · FCHS · CHE · ASTH · GBCS · ADUS · NHC
Which Other Stocks Score Like FOXO on Quality?
Closest companies to FOXO’s Quality of Company score of 3.9/10, across all industries.
- ESSI — Eco Science Solutions, Inc. (QOC 3.9) · analysis
- DWTX — Dogwood Therapeutics, Inc. (QOC 3.9) · analysis
- OLOX — Olenox Industries Inc. (QOC 3.9) · analysis
- MBRX — Moleculin Biotech, Inc. (QOC 3.9) · analysis
- WHK — WhiteHawk Minerals Corp. (QOC 3.9) · analysis
- DFDV — DeFi Development Corp. (QOC 3.9) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Care Facilities Screens Does FOXO Appear In?
So Is FOXO Technologies Inc. (FOXO) Worth Buying in 2026?
FOXO Technologies Inc. currently lacks sufficient model coverage for a definitive valuation conclusion. We recommend monitoring as additional SEC filing data becomes available.
These are quantitative model outputs, not investment recommendations. FOXO Technologies Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About FOXO Stock?
Should I buy FOXO stock right now?
Based on CirclFi's multi-model analysis, 0 of 0 models see upside for FOXO at $0.09. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in FOXO Technologies Inc.?
Key risks include: an elevated Value Trap score of 53/100, suggesting apparent undervaluation may mask deteriorating fundamentals; a below-average Quality Score of 3.9/10, indicating fundamental weakness; limited model coverage (0/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.
How does FOXO compare to its competitors?
Among Medical Care Facilities peers, FOXO holds a Quality Score of 3.9/10. Comparable companies include HLYK (QOC 4.1), PARK (QOC 3.9), CMPS (QOC 4.5). The relative ranking helps investors identify whether FOXO offers better fundamental quality than alternatives in the same sector.
Is FOXO a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. FOXO's Quality Score of 3.9/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy FOXO at?
CirclFi does not provide target buy prices or price alerts. However, our 0 active models produce fair value estimates ranging from — to —. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for FOXO.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad